期刊文献+

干燥综合征血清性激素水平与白细胞介素-6的相关性研究 被引量:5

The study on sex hormones and interleukin-6 in postmenopausal women with primary Sjgren′s syndrome
原文传递
导出
摘要 目的探讨性激素和白细胞介素(IL)-6在原发性干燥综合征(primarySj!gren′ssyn-drome,pSS)发病机制中的作用及其相关性。方法以21例绝经后女性pSS患者作为疾病组,21名绝经后健康女性作为对照组,分别采集血清标本,应用放射免疫法测定雌二醇(E2)和睾酮(Te)水平,应用化学发光法测定硫酸脱氢表雄酮(DHEAS)水平,应用酶联免疫吸附法测定IL-6水平。结果绝经后女性pSS患者血清DHEAS及Te水平低于健康对照组(P<0.01),血清E2水平与健康对照组比较差异无统计学意义(P>0.05)。患者血清IL-6水平高于健康对照组(P<0.01),血清DHEAS、Te与IL-6水平呈负相关关系(r=-0.738,P<0.01;r=-0.514,P<0.05),血清E2与IL-6水平无相关关系(r=0.340,P>0.05)。结论pSS患者存在性激素代谢异常,性激素与IL-6共同参与pSS的发病。 Objective To investigate the role of sex hormones and interleukin (IL)-6 in the pathogenesis of primary Sjtigren's syndrome (pSS). Methods Serum specimen of 21 postmenopausal patients with pSS and 21 postmenopausal healthy women were collected. Serum estradiol (E2) and testosterone (Te) were estimated by the commercial radioimmunoassay kits, whereas serum dehydroepiandrosterone sulfate (DHEAS) were measured by enzyme-amplified chemiluminescence assay. Enzyme linked immunosorbent assay kits were used to determine levels of IL-6 in serum. Results The DHEAS and the Te level in serum were lower in postmenopausal patients with pSS than in healthy controls (P〈0.01). There was no significant difference in serum E2 level (P〉0.05). The level of IL-6 in pSS patients was higher than that in controls (P〈0.01). The serum levels of DHEAS and Te were negatively correlated with the concentration of IL-6 (r=-0.738, P〈0.01, r=-0.514, P〈0.05), but there was no correlation between E2 level and the serum IL-6 level in pSS patients after menopause (r=0.340, P〉0.05). Conclusion Primary Sjogren's syndrome, in which an altered metabolism of sex hormones has occured, appears to be influenced by the change of the levels of sex hormones and IL-6 in serum.
作者 孙文闻 巩路
出处 《中华风湿病学杂志》 CAS CSCD 2006年第1期36-39,共4页 Chinese Journal of Rheumatology
关键词 干燥综合征 睾酮 硫酸脱氢表雄酮 雌二醇 白细胞介素6 Sjogren' s syndrome Testosterone Dehydroepiandrosterone sulfate Estradiol Interleukin-6
  • 相关文献

参考文献13

  • 1Johnson EO,Skopouli FN,Moutsopoulos HM.Neuroendocrine manifestations in Sjogren's syndrome.Rheum Dis Clin North Am,2000,26:927-949.
  • 2Sullivan DA,Sato EH.Potential therapeutic approach for the hormonal treatment of lacrimal gland dysfunction in Sjogren's syndrome.Clin Immunol Immunopathol,1992,64:9-16.
  • 3Vendramini ACLM,Soo C,Sullivan DA.Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjogren's syndrome.Invest Ophthalmol Vis Sci,1991,32:3002-3006.
  • 4Ono M,Rocha FJ,Sullivan DA.Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-lpr/lpr mouse model of Sjogren's syndrome.Exp Eye Res,1995,61:659-666.
  • 5Nagler RM,Pollack S.Sjogren's syndrome induced by estrogen therapy.Semin Arthritis Rheum,2000,30:209-214.
  • 6Rifé SU,Márquez MG,Escalante A,et al.The effect of testosterone on the immune response 1:mechanism of action on antibody-forming cells.Immunol Invest,1990,19:259-270.
  • 7Sato EH,Sullivan DA.Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjogren's syndrome.Invest Ophthalmol Vis Sci,1994,35:2632-2642.
  • 8Ho PC,Tang GWK,Lawton JWM.Lymphocyte subsets and serum immunoglobulins in patients with premature ovarian failure before and after oestrogen replacement.Human Reproduction,1993,8:714-716.
  • 9Nilsson N,Carlsten H.Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation.Cell Immunol,1994,158:131-139.
  • 10Wang D,Chan EKL.17-β-estradiol increases expression of 52 000 and 60 000 SS-A/Ro autoantigens in human keratinocytes and breast cancer cell line MCF-7.J Invest Dermatol,1996,107:610-614.

同被引文献26

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部